Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Cavalli

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomasEmanuele Zucca, Francesco Bertoni, Barbara Vannata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Cancer Prevention and Interception: A New Era for Chemopreventive ApproachesAdriana Albini, Andrea DeCensi, Franco Cavalli, et al.
Hematological Oncology|January 13, 2006
Update on the molecular biology of mantle cell lymphomaFrancesco Bertoni, Andrea Rinaldi, Emanuele Zucca, et al.
Hematology/Oncology Clinics of North America|October 29, 2008
Marginal zone lymphomasEmanuele Zucca, Francesco Bertoni, Anastasios Stathis, et al.
Current Oncology Reports|August 23, 2018
Toward a Risk-Tailored Therapeutic Policy in Mantle Cell LymphomaAdalgisa Condoluci, Davide Rossi, Emanuele Zucca, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
Genetic alterations underlying the pathogenesis of MALT lymphomaFrancesco Bertoni, Franco Cavalli, Finbarr E Cotter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Primary CNS lymphomas prognosisAndrés J M Ferreri, Michele Reni, Emanuele Zucca, et al.
Nature Reviews. Clinical Oncology|August 12, 2010
Flows and flaws in primary central nervous system lymphomaAndrés J M Ferreri, Gerald Illerhaus, Emanuele Zucca, et al.
British Journal of Haematology|May 31, 2008
Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphomaDavide Soldini, Oreste Mora, Franco Cavalli, et al.
Journal of Hematology & Oncology|November 25, 2010
Targeted therapy in lymphomaPatrick B Johnston, RuiRong Yuan, Franco Cavalli, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2014
Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomasEmanuele Zucca, Francesco Bertoni, Barbara Vannata, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2016
Cancer Prevention and Interception: A New Era for Chemopreventive ApproachesAdriana Albini, Andrea DeCensi, Franco Cavalli, et al.
Hematological Oncology|January 13, 2006
Update on the molecular biology of mantle cell lymphomaFrancesco Bertoni, Andrea Rinaldi, Emanuele Zucca, et al.
Hematology/Oncology Clinics of North America|October 29, 2008
Marginal zone lymphomasEmanuele Zucca, Francesco Bertoni, Anastasios Stathis, et al.
Current Oncology Reports|August 23, 2018
Toward a Risk-Tailored Therapeutic Policy in Mantle Cell LymphomaAdalgisa Condoluci, Davide Rossi, Emanuele Zucca, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|April 18, 2002
Genetic alterations underlying the pathogenesis of MALT lymphomaFrancesco Bertoni, Franco Cavalli, Finbarr E Cotter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Primary CNS lymphomas prognosisAndrés J M Ferreri, Michele Reni, Emanuele Zucca, et al.
Nature Reviews. Clinical Oncology|August 12, 2010
Flows and flaws in primary central nervous system lymphomaAndrés J M Ferreri, Gerald Illerhaus, Emanuele Zucca, et al.
British Journal of Haematology|May 31, 2008
Efficacy of alemtuzumab and gemcitabine in a patient with enteropathy-type T-cell lymphomaDavide Soldini, Oreste Mora, Franco Cavalli, et al.
Journal of Hematology & Oncology|November 25, 2010
Targeted therapy in lymphomaPatrick B Johnston, RuiRong Yuan, Franco Cavalli, et al.
Pageof 16